2025 Analysis: Opportunities and Risks in the Evolving Pharmaceutical Continuous Manufacturing Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Pharmaceutical Continuous Manufacturing Industry?
The market size of the pharmaceutical continuous manufacturing sector has seen significant growth in the past few years. The market is projected to expand from $2.47 billion in 2024 to $2.69 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. This development in the historical period is a consequence of improvements in quality and efficiency, reduction in time-to-market, cost reduction and operational efficiency, regulatory support and guidelines, as well as flexibility and scalability.
In the coming years, the pharmaceutical continuous manufacturing market is projected to experience significant growth. It is anticipated to reach a value of $4.08 billion by 2029, rising at a compound annual growth rate (CAGR) of 10.9%. The expansion predicted during this period is due to factors such as growth in generic drug production, biopharmaceutical manufacturing, personalized medicine production and a focus on patient-centric approaches. The period is also likely to witness major trends including the adoption of continuous manufacturing, process analytical technology integration, utilization of sophisticated automation and robotics, strategic collaborations and partnerships, along with more digitalization and connectivity.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
What Forces Are Driving The Growth Of The Pharmaceutical Continuous Manufacturing Industry?
The escalating incidence of numerous long-term health issues is predicted to boost the advancement of the pharmaceutical continuous manufacturing market. These chronic conditions are typically characterized as ailments that linger for a year or more, necessitating ongoing medical care, and disrupting day-to-day activities. Continuous manufacturing methods offer pharmaceutical firms the potential to make drug production more efficient, which leads to enhanced productivity and reduced expenses. It also widens the accessibility of crucial medications, which is particularly vital for the management of chronic diseases necessitating prolonged use of medications. For example, a report published by the National Association of Chronic Disease Directors (NACDD), a non-profit US public health organization focusing on chronic disease initiatives, stated in April 2022 that nearly 60% of American adults suffer from at least one chronic disease, and around 40% have multiple chronic conditions (MCC). This is projected to impose an annual cost of $2 trillion on the US economy, or $8,600 per individual by 2030. Hence, the escalating incidence of numerous chronic diseases is set to fuel the progress of the pharmaceutical continuous manufacturing market.
What Is The Overview Of Market Segmentation In The Pharmaceutical Continuous Manufacturing Industry?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
What Future Market Trends Are Projected For The Pharmaceutical Continuous Manufacturing Industry?
Technological advancements are emerging as a significant trend in the pharmaceutical continuous manufacturing market, with leading industry players introducing new offerings aimed at maintaining their market positions. For instance, in December 2022, The United States Pharmacopeia (USP) unveiled the USP Advanced Manufacturing Technology Lab as well as research and development analytical solutions. This US-based non-profit organization holds both the trademark and copyright for the Pharmacopeia National Formulary (USP-NF). The role of these analytical lab services is to help drug manufacturers embrace sophisticated manufacturing technologies like pharmaceutical continuous manufacturing (PCM). This not only broadens the geographic diversity in pharmaceutical production but also enhances the resilience of the medicine supply chain. It involves describing materials, creating and qualifying methods to support and ensure the quality of PCM-based drugs.
Who Are The Primary Players Operating Across The Global Pharmaceutical Continuous Manufacturing Market?
Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Get The Full Report Here:
Which Region Offers The Most Growth Potential For The Pharmaceutical Continuous Manufacturing Market Through 2029?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
